The FDA and EMA's joint guidance was created to ensure the pharmaceutical industry employs best practices when using AI in ...
A portable device that can instantly detect dangerous street drugs at extremely low concentrations has been developed at the University of Bath in the UK. The device, which is being trialled by ...
ATLANTA — Artificial intelligence is revolutionizing drug development, significantly reducing the time it takes to bring life-saving treatments to market, drug companies say. Traditionally, developing ...
FDA and EMA have issued 10 guiding principles for AI in drug development with the intended goal of ensuring safety and ...
AlphaFold, a transformative AI-driven tool developed by DeepMind, has revolutionized the field of structural biology by accurately predicting protein structures. This breakthrough holds significant ...
New drug discovery is a critical step for improving patients' lives. First, researchers must identify molecules in the body's cells that help drive disease, as these are potential targets for new ...
LOS ANGELES (AP) — Drug testing is coming to e-sports. The Electronic Sports League said Thursday it will begin randomly drug testing players at its competitive video game tournaments. The e-sports ...
Scientists have developed a revolutionary AI "fingerprint" technology that can accurately show how cancer cells respond to new drugs, by simply observing changes to their shape. The new technology, ...
Maddy has a degree in biochemistry from the University of York and specializes in reporting on health, medicine, and genetics. Maddy has a degree in biochemistry from the University of York and ...
A team has developed a large-scale drug screening technique that can track target molecule behavior within cells. The researchers verified their technique by testing the epidermal growth factor ...
The pharmaceutical industry is entering an inflection point driven by the recognition that highly potent cancer drugs are only as effective as their ability to reach tumors with sufficient ...
Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. The pharmaceutical industry faces the challenge of balancing innovation with affordability.